NASDAQ: ENVB - Enveric Biosciences, Inc.

Yield per half year: +13.01%
Sector: Healthcare

Enveric Biosciences, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
2.15 48.77 -95.59% -0.5733 -475.03%
P/S 0 33.76 -100%
P/BV 0.7552 4.82 -84.34%
P/FCF -0.5248 60.98 -100.86%
Ev/Ebitda -0.035 -22.12 -99.84%
Ev/S 0 22.56 -100%
Ev/FCF -0.0399 68.75 -100.06%
E/P -2.34 0.0178 -13265.53%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.83 -100% -10.58 -100%
ROE -458.69 9.61 -4874.94%
ROA -282.97 0.3359 -84341.64%
ROIC 0 7.63 -100%
ROS 0 -25.17 -100%
ROCE -435.84 15.33 -2942.82%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.004 -3.67 -99.89% -0.1555 -97.43%
Nеt Debt/Ebitda 0.1426 -3.44 -104.15%
Debt/Ratio 0.0105 0.1972 -94.69%
Debt/Equity 0.0035 1.65 -99.79%
Debt/Net Income -0.0037 10.31 -100.04%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5496 -100% 0 0%
Number of years of dividend growth 1 0.1053 850%
DSI 0.5 0.2174 129.97%
Average dividend growth 0 0.0654 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
2/10
10.43 -56.89 -118.33%
Growth impulse Ebitda 5 years -99.6 -64.81 53.68%
Growth impulse Net Income 5 years -99.69 -58.33 70.91%
Growth impulse FCF 5 years 455.66 -47 -1069.49%
Growth impulse EPS 5 years -98.46 -32.41 203.8%
IP Score
3.89/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences